Invion (ASX:IVX) - Executive Chair & CEO, Thian Chew
Executive Chair & CEO, Thian Chew
Source: Thian Chew/LinkedIn
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • Invion (IVX) is aiming to raise $15 million in additional capital to help fund the expansion of its Photosoft technology co-development deal
  • IVX and RMW Cho Group will co-develop the tumour regression treatment technology for use on cancer and related diseases
  • Invion will hand over $5 million towards the development costs, and in return receive exclusive distribution rights in the Asia Pacific region
  • The ASX-lister is hoping to raise $3 million in extra cash through a share placement plan and has received commitments for a $12 million placement
  • IVX shares have come out of a trading halt and are down 11.1 per cent at 2.4 cents each

Invion (IVX) is aiming to raise $15 million in additional capital to help fund the expansion of its Photosoft technology co-development deal.

The life-sciences company came out of a trading halt today to announce the fundraise, expanded development deal and new license and distribution agreement.

Specifically, IVX and RMW Cho Group will co-develop Photosoft technology, a tumour regression treatment, for use on cancer and related diseases.

Invion will hand over $5 million towards the development costs, and in return receive exclusive distribution rights in the Asia Pacific region.

The ASX-lister already holds the exclusive Australia and New Zealand license rights to
Photosoft for certain conditions, while RMW is the technology licenser.

To help fund the new agreements, IVX has completed a $12 million placement to investors, issuing 545 million new shares at 2.2 cents each.

A free attaching option will be issued for every 2nd share subscribed for, with an issue price of 4 cents and an expiry date 18 months from the time of issue.

Additionally, the company will carry out a $3 million share purchase plan (SPP) for IVX shareholders, with new shares also priced at 2.2 cents each.

Placement shares are due to settle on November 19, while the SPP opens next Monday and closes on December 3.

After resuming trade on Tuesday, Invion shares were trading down 11.1 per cent at 2.4 cents each at 12:50 pm AEDT.

IVX by the numbers
More From The Market Online
The Market Online Video

Monday’s HotCopper Highlights: Circling Star buyer, Boss’ $8M earn-in | March 10, 2025

The ASX 200 has handed back some of its mid-morning gains to settle at 7,968 points so far on Monday; a 0.2% gain...
The Market Online Video

Tuesday’s HotCopper Highlights: Hot Chili leadership, BluGlass’ world-record laser | March 11, 2025

Australian shares have retreated as much as 1% today, down by more than 80 points, following panic in the U.S.
Raw lithium on a conveyer belt

LPM progresses through Bynoe lithium development activities

Lithium Plus Minerals Ltd has been busy with a flurry of diverse activities connected to development…
Market Close Graphic

ASX Market Close: Index pares losses as US recession fears rise | March 11, 2025

The ASX200 closed down 0.9% at 7,890 points.